Jorge E. V.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination with Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Comparative Study of Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 and Nivolumab in Untreated Advanced Melanoma Patients
Data & Insights
Has run more than one trial at 0 of 27 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of advanced melanoma, with particular emphasis on post-surgical therapeutic approaches for patients with completely resected disease.
- Stage IIB Melanoma Management
- Stage IIC Melanoma Treatment
- Stage III Melanoma Care
The investigator's work centers on evaluating novel therapeutic options for adjuvant treatment in melanoma patients who have undergone complete surgical resection.
Therapeutic Expertise
Demonstrates specialized knowledge in immunotherapy approaches for melanoma treatment, particularly in the adjuvant setting following surgical intervention.
- Post-Surgical Therapy
- Adjuvant Treatment Protocols
- Immunological Interventions
The investigator focuses on developing and assessing treatment strategies for patients with high-risk resected melanoma.
Clinical Focus
Specializes in the evaluation of therapeutic alternatives for melanoma patients, with emphasis on comparative assessment of treatment options.
- Treatment Comparisons
- Clinical Assessment
- Patient Monitoring
The investigator's expertise extends to evaluating therapeutic interventions in the context of melanoma disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.